| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $118.10 | $24.52 | 381.69% | 222.83x | 202.43x | 14.98x | 18.09x | 1.73x | $106.92M | 0.86% | $705.78M | 6.70 | $12.66B | 1,614.38 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $228.61 | $94.52 | 141.86% | 37.48x | 31.56x | 6.36x | 22.59x | 1.14x | $793.95M | 2.60% | $1.35B | 10.14 | $31.87B | 27.02 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $79.49 | $16.41 | 384.44% | 74.29x | 63.14x | 7.33x | 9.48x | 2.30x | $182.84M | 2.97% | $654.15M | 8.43 | $6.04B | 50.31 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.54 | $8.30 | 219.86% | 126.38x | 164.95x | 7.47x | 15.12x | 1.17x | $39.15M | 1.13% | $220.58M | 1.69 | $3.42B | 75.24 | ||
| ADMA | ADMA BIOLOGICS INC | $9.54 | $8.73 | 9.31% | 13.25x | 11.37x | 4.25x | 5.23x | 0.60x | $116.47M | 5.35% | $408.21M | 1.79 | $2.20B | 9.44 | ||
| HALO | HALOZYME THERAPEUTICS INC | $104.89 | $70.81 | 48.12% | 29.46x | 12.64x | 7.39x | 82.94x | 0.63x | $806.22M | 6.55% | $143.54M | 1.22 | $13.89B | 19.33 | ||
| VCEL | VERICEL CORP | $44.26 | $8.88 | 398.32% | 92.21x | 91.81x | 7.38x | 6.12x | 2.18x | $61.66M | 2.73% | $370.04M | 7.25 | $2.23B | 50.71 | ||
| RPRX | ROYALTY PHARMA PLC | $59.69 | $38.48 | 55.13% | 31.75x | 11.12x | 10.48x | 3.51x | 0.66x | $2.92B | 11.01% | $9.79B | 21.99 | $42.47B | 36.11 | ||
| KRYS | KRYSTAL BIOTECH INC | $332.82 | $86.28 | 285.74% | 40.24x | 43.64x | 22.31x | 7.25x | 2.37x | $257.78M | 2.62% | $1.36B | 46.03 | $9.43B | 40.43 | ||
| TGTX | TG THERAPEUTICS INC | $50.26 | $23.83 | 110.91% | 16.32x | 35.67x | 8.91x | 12.74x | 1.91x | $17.39M | 0.24% | $604.08M | 4.26 | $7.96B | 57.19 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.57 | $9.43 | 22.64% | 12.18x | 11.17x | 5.03x | 3.16x | 0.79x | $82.01M | 11.98% | $217.65M | 3.68 | $543.25M | 7.03 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $66.99 | $21.21 | 215.77% | 176.29x | 18.03x | 3.80x | 2.05x | 1.11x | $738.18M | 5.70% | $6.32B | 32.68 | $16.28B | 42.21 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.06 | $2.24 | 36.90% | 15.30x | 13.24x | 1.88x | 2.93x | 0.79x | $5.67M | 2.35% | $82.53M | 1.04 | $177.71M | 9.51 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $287.59 | $93.30 | 208.23% | 28.56x | 31.12x | 19.86x | 5.93x | 2.14x | $130.62M | 2.26% | $967.52M | 48.22 | $5.86B | 21.00 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $528.19 | $156.84 | 236.78% | 30.48x | 27.31x | 10.65x | 6.61x | 2.41x | $3.80B | 2.83% | $20.25B | 79.81 | $129.71B | 23.57 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $253.07 | $194.62 | 30.03% | 16.58x | 9.80x | 3.48x | 3.42x | 0.68x | $1.62B | 10.13% | $4.80B | 75.98 | $19.20B | 11.88 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.20 | $6.43 | -81.35% | 8.57x | -4.06x | 1.48x | 1.58x | 0.07x | $19.58M | 28.17% | $44.20M | 0.76 | $21.15M | 2.77 | ||
| TECH | BIO-TECHNE CORP | $72.22 | $15.92 | 353.51% | 101.72x | 34.61x | 9.32x | 5.42x | 1.87x | $269.60M | 2.39% | $2.09B | 13.34 | $11.39B | 44.49 | ||
| MDXG | MIMEDX GROUP INC | $4.34 | $1.11 | 292.51% | 108.50x | -38.68x | 1.81x | 2.93x | 1.53x | $44.50M | 6.94% | $216.00M | 1.46 | $513.97M | 22.53 | ||
| EXEL | EXELIXIS INC | $53.12 | $28.38 | 87.19% | 16.15x | 16.51x | 5.47x | 7.14x | 1.43x | $1.17B | 8.80% | $1.84B | 7.35 | $13.05B | 11.99 | ||
| UTHR | UNITED THERAPEUTICS CORP | $518.27 | $223.17 | 132.23% | 17.14x | 18.94x | 7.00x | 3.47x | 2.31x | $1.09B | 4.95% | $6.40B | 150.24 | $20.43B | 12.18 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $810.24 | $414.18 | 95.63% | 19.32x | 17.35x | 5.36x | 2.63x | 1.27x | $3.76B | 4.51% | $31.71B | 308.48 | $83.67B | 14.55 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.83 | $32.74 | 18.60% | 12.37x | 10.23x | 2.34x | 2.26x | 0.73x | $354.90M | 15.78% | $999.24M | 17.25 | $1.87B | 6.66 | ||
| INCY | INCYTE CORP | $123.47 | $60.07 | 105.55% | 15.21x | 16.24x | 4.25x | 3.94x | 2.03x | $1.92B | 7.76% | $6.34B | 31.66 | $21.08B | 10.19 |